Search results for:
cimetidine
cimetidine
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Tagamet |
LIQUID, ORAL |
300 mg/5 mL |
|
|
|
|
| Tagamet |
SOLUTION, INTRAVENOUS |
150 mg/mL |
|
|
|
|
| Tagamet |
TABLET, ORAL |
200 mg, 300 mg, 400 mg, 800 mg |
|
|
|
|
Last updated: Mar. 1, 2018
If H2 blocker prescribed with PPO, discontinue H2 blocker after 48 hours. Exception if GI physician -- check with physician that H2 blocker is not being used for a non-GI use prior to discontinuing.
Automatic IV to PO conversion per IV to oral conversion guidelines. IV to PO Conversion Guidelines
Automatic renal adjustment per guidelines. Renal Adjustment Guidelines See H2-Receptor Blocker Formulary document for renal dosing recommendations.